Article
Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti-Tuberculosis Drug-Induced Liver Injury.
Journal of clinical pharmacology - 1 Feb 2025
Han Bing, He Yiwen, Zhu Min, Zhang Meiling, Lu Lihuan, Xu Xiaoyan, He Xiaomin, Yi Honggang, Tang Shaowen
Abstract excerpt
The accumulation of protoporphyrin IX in the liver caused by isoniazid and rifampicin through the disorder of heme biosynthesis was considered an important mechanism of anti-tuberculosis drug-induced liver injury (ATLI). Alanine synthase 1 (ALAS1) is a rate-limiting enzyme in the process of heme synthesis. This study aimed to investigate the association between ALAS1 gene polymorphism, serum ALAS1 level, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
